Upstream Bio Inc (NASDAQ: UPB) on Tuesday, plunged -6.22% from the previous trading day, before settling in for the closing price of $18.02. Within the past 52 weeks, UPB’s price has moved between $5.14 and $29.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 50.04%. With a float of $19.89 million, this company’s outstanding shares have now reached $53.80 million.
The extent of productivity of a business whose workforce counts for 52 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -4464.6%, and the pretax margin is -3836.58%.
Upstream Bio Inc (UPB) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Upstream Bio Inc is 63.10%, while institutional ownership is 52.99%. The most recent insider transaction that took place on Oct 15 ’24, was worth 14,025,000. In this transaction Director of this company bought 825,000 shares at a rate of $17.00, taking the stock ownership to the 4,554,873 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Director bought 825,000 for $17.00, making the entire transaction worth $14,025,000. This insider now owns 4,554,873 shares in total.
Upstream Bio Inc (UPB) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -6.96 earnings per share (EPS) for the period falling under the consensus outlook (set at -3.65) by -3.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.04% per share during the next fiscal year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
Upstream Bio Inc (UPB) is currently performing well based on its current performance indicators. A quick ratio of 38.27 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 334.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.98 in one year’s time.
Technical Analysis of Upstream Bio Inc (UPB)
The latest stats from [Upstream Bio Inc, UPB] show that its last 5-days average volume of 0.48 million was superior to 0.36 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 67.21%.
During the past 100 days, Upstream Bio Inc’s (UPB) raw stochastic average was set at 82.64%, which indicates a significant increase from 52.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.35 in the past 14 days, which was higher than the 0.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.02, while its 200-day Moving Average is $12.82. Now, the first resistance to watch is $17.92. This is followed by the second major resistance level at $18.93. The third major resistance level sits at $19.64. If the price goes on to break the first support level at $16.19, it is likely to go to the next support level at $15.48. Assuming the price breaks the second support level, the third support level stands at $14.47.
Upstream Bio Inc (NASDAQ: UPB) Key Stats
Market capitalization of the company is 911.07 million based on 53,909K outstanding shares. Right now, sales total 2,370 K and income totals -62,810 K. The company made 940 K in profit during its latest quarter, and -39,970 K in sales during its previous quarter.
